Agilent reports strong growth for second quarter of 2017

Agilent Technologies has announced its financial results for the second quarter of 2017, during which it generated a revenue total of $1.1 billion (847.65 million pounds).

This represented a year-on-year increase of eight percent, or nine percent on a core basis, while its GAAP net income figure jumped to $164 million, up from $91 million during the corresponding quarter of last year.

The firm's life sciences and applied markets group saw its performance bolstered by double-digit growth in the chemical and energy, pharma and environmental markets, while the CrossLab Group continued to see solid growth across all geographies.

Additionally, Agilent's diagnostics and genomics group saw a strong result from its pharma and diagnostic and clinical end-markets.

Based on these encouraging Q2 figures, Agilent is raising its full-year core revenue growth and earnings expectations, with revenue of between $4.36 billion and $4.38 billion expected for the full 12 months.

Mike McMullen, Agilent's president and chief executive officer, said: "We continue to deliver on our long-term focus of driving above-market growth, expanding operating margins and deploying capital in a balanced manner."

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.